… Recent studies have shown CD34 + -selected stem cell boost (CD34 … graft function and
survival outcomes [4, 5]. We aimed to investigate outcomes following CD34 + -SCB for PGF after …

… study warrants the use of CD34+selected donor cells, without further conditioning, for
patients with primary or secondary poor graft function in the presence of full donor chimerism. …

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts
after … In this study, we followed surviving patients for a median of 43 months (range 8–74 …

… Over the past decades, most studies of the treatment of PGF have been focused on the use
of CD34 + -selected stem-cell boost without pre-conditioning, leading to favorable outcomes. …

… outcomes of a CD34 + -selected stem cell boost (SCB) without prior conditioning in 32 patients
(male/22; median age of 54 years; range, 20 to 69) with poor graft function, … the follow-up …

… Poor graft function without rejection may occur after stem cell … of CD34 + -selected SCB in
some patients with poor graft … in some patients following allogeneic stem cell transplantation (…

… With the rapid development of haploidentical hematopoietic stem cell transplantation, the …
in some success in CD34 + -selected stem cell boosting. Mesenchymal stem cells, N-acetyl-l-…

… After a median follow-up of 7.5 months (range, 1 to 48 months… treated with a boost of CD34
+ -selected stem cells without further … No favorable outcomes were observed in these studies, …

… Favorable outcomes following CD34-selected stem cell 28 boost for poor graft function after
… CD34+ selected stem cell “Boost” for poor graft function after 37 allogeneic hematopoietic …

… CD34 + selected stem cell boost (SCB) after allogeneic hematopoietic cell transplantation
(alloHCT), predominantly for poor graft … PGF following alloHCT is a rare complication after …